Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We studied cytokine profiles in
BAL
of LTRs with Aspergillus spp colonization who did not progress to
IPA
in the absence of antifungal prophylaxis. This was a retrospective, single center case-control study.
BAL
samples were analyzed for cytokines. Patients with Aspergillus spp in
BAL
who did not receive prophylaxis and did not develop
IPA
were compared to LTRs with Aspergillus spp that received prophylaxis, LTRs with
IPA
and controls. Twenty-one patients with Aspergillus colonization who did not develop
IPA
, seven patients with suspected
IPA
who received prophylaxis, 4
IPA
and 19 controls were included.
IPA
group had significantly higher levels (median [IQR]) of MIP-1 beta compared to the Suspected
IPA
group (5 vs 5 P: 0.03). The Suspected
IPA
group had significantly higher levels of IL-12 (11.38 vs 1 P: 0.0001), IL-1 RA (86.11 vs 23.98 P: 0.0118), IP-10 (22.47 vs 0.86 P: 0.0151), HGF (40.92 vs 16.82 P: 0.0055), and MIG (169.62 vs 5 P: 0.0005) than Colonization group. We have identified a unique cytokine signature in patients with Aspergillus colonization that do not develop
IPA
. Our study forms basis for a larger study to use these cytokines profile to identify patients at a lower risk of developing
IPA
.
...
PMID:Cytokine profile in lung transplant recipients with Aspergillus spp colonization. 3075 47